tion abnormalities. Conclusions: TAVI is associated with a reduction in SPAP. A postprocedural wide QRS and normal PR interval may unfavorably influence the left-sided filling performance, resulting in an increased LA volume. Other diastolic parameters, as well as survival, are not significantly affected by postprocedural conduction abnormalities.
Introduction
Left ventricular (LV) diastolic dysfunction is reported in approximately 50% of patients with aortic stenosis and a normal systolic ejection performance, and in 100% of those with depressed LV function [1] . Left bundle branch block (LBBB) is associated with an impaired systolic and diastolic function [2] [3] [4] , while PR prolongation is associated with a decreased ejection fraction [5] . In patients with severe aortic stenosis, transcatheter aortic valve implantation (TAVI) may result in improved LV diastolic properties [6] [7] [8] . On the other hand, TAVI may cause conduction disturbances including PR prolongation and LBBB [9] [10] [11] . New-onset LBBB after TAVI can be the cause of failure of the LV ejection fraction to improve in short-and long-term follow-up, despite the procedural success [12] , and similarly may mitigate the impact of the procedure on LV diastolic performance. The aim of the study was to evaluate the relation between conduction disturbance and diastolic function in patients undergoing TAVI.
Methods
Our study population included consecutive patients undergoing transfemoral TAVI for the treatment of severe aortic valve stenosis using the Edwards Sapien/Sapien XT prosthesis (Edwards Lifesciences, Irvine, CA, USA) or the Medtronic CoreValve prosthesis (MCV; Medtronic, Minneapolis, MN, USA) at a tertiary university hospital between 2009 and 2012. The institutional ethics committee approved the study.
The inclusion criteria for TAVI were a logistic EuroSCORE >20, porcelain aorta, previous chest radiation, a logistic Euro-SCORE >10, and 1 of the following: cachexia [13] , the need for assistance in basic daily activities [14] , or previous open heart surgery. Eligibility for TAVI was determined by the institutional Heart Team, comprising an interventional cardiologist, echocardiologists, and a cardiothoracic surgeon.
Patients undergoing TAVI were enrolled in a prospective registry recording procedural information as well as clinical and echocardiographic data collected at baseline, 30 days, and 6 months. Measurement of diastolic parameters was not routine in all patients, and therefore only patients in whom these parameters were measured were included in the current study. All patients without exclusion criteria were included in the current study.
The exclusion criteria for this study were as follows: atrial fibrillation during echocardiographic and electrocardiogaphic data collection, patients with a permanent pacemaker (either implanted before the TAVI procedure or after it due to AV block), and patients with incomplete echocardiographic or electrocardiographic (ECG) data.
Transthoracic echocardiographic data were obtained with a standardized protocol. LV linear dimensions were measured in the parasternal long-axis view. Early (E) transmitral filling peak velocity, atrial (A) transmitral filling peak velocity and deceleration time (DT) were obtained with pulsed wave Doppler sample at the tip of the mitral valve leaflet [15] . Early velocity of the septal and lateral aspects of the mitral annulus was measured using tissue Doppler imaging. Mitral annulus velocity (e ′ ) was defined as the average of septal and lateral velocities [15] . Left atrial (LA) volume was determined using the biplane area-length or dimension-length methods [16] . Systolic pulmonary artery pressure (SPAP) was estimated using tricuspid regurgitation velocity as well as appearance and respiratory changes of inferior vena cava [17] . Echo Doppler indexes of aortic stenosis severity included the maximal velocity (Vmax) across the aortic valve, the mean pressure gradient and the aortic valve area (AVA), calculated using the standard continuity equation [16] . Severe aortic stenosis was defined as Vmax >4 m/s, mean pressure gradient >40 mm Hg, and AVA <1.0 cm 2 [18] .
For ECG data we used simultaneous ECG recordings performed during the echocardiographic study. ECG intervals were obtained with traces performed at the time of mitral inflow pulsed Doppler or mitral annulus tissue Doppler imaging. The values of PR, QRS, and QT, were obtained at baseline and 30 days after TAVI. Corrected QT (QTc) was calculated using the Bazzet formula [19] . The clinical endpoint was overall survival.
Statistical Analysis
Continuous normally distributed parameters are presented as the mean ± SD and were compared using the Student t test. All p values were 2-sided and p < 0.05 was considered statistically significant. Correlations were assessed with the Pearson correlation test. Event-free survival was calculated according to the KaplanMeier method. All data were analyzed with JMP System software version 8.0 (SAS Institute Inc., Cary, NC, USA).
Results
Of the 344 consecutive patients who underwent TAVI, 141 patients were excluded due to incomplete or absent echo-Doppler data, 53 because of atrial fibrillation, 34 Data are presented as the mean ± SD or n (%). due to poor-quality ECG recordings, and 15 due to the presence of a permanent pacemaker. Of note, 40 patients developed a complete AV block following TAVI. These patients were already excluded due to incomplete data or the presence of a permanent pacemaker, which was also an exclusion criterion. Thus, the study population consisted of 101 patients, of whom 30 were implanted with the Edwards Sapien/Sapien XT prosthesis and 71 with the MCV prosthesis. Table 1 presents the baseline demographic and clinical characteristics of the entire cohort. Table 2 presents ECG measurements at baseline assessment and at 1 month after TAVI. There was a significant prolongation in QRS width ( p = 0.021) and no significant change of other variables at 1 month after TAVI compared to baseline.
Echocardiographic and ECG Measurements
The diastolic echo-Doppler parameters at baseline, 1 and 6 months after TAVI are presented in Table 3 . There was a progressive reduction in SPAP at 1 month ( p = 0.014), and at 6 months after the procedure ( p = 0.005). In addition, there was a trend towards a prolongation in E wave DT at 6 months compared to baseline ( p = 0.056). All other parameters showed no significant change over time during the study period.
Correlation between the ECG and Diastolic Echocardiographic Parameters
In order to better understand the interaction between ECG intervals and diastolic parameters, we performed the following correlations: (1) postprocedural ECG (PR and QRS) intervals and diastolic parameters post-TAVI at 1 and 6 months, and (2) changes (Δ) in ECG intervals and changes in diastolic parameters at 1 and at 6 months.
At 1 month, there was a weak, albeit significant negative correlation between QRS width and E wave DT ( r = -0.21, p = 0.03), and, at 6 months, there was a weak, positive correlation between ΔPR with ΔE/e ′ ( r = 0.28, p = 0.01).
Analysis according to PR Interval and ΔPR
We next compared diastolic parameters in patients with a normal (<200 ms), and those with a long ( ≥ 200 ms) PR interval 1 month after TAVI ( Table 4 ). There was no significant difference in diastolic echocardiographic parameters between the 2 groups at 1 month. However, at 6 months after TAVI, patients with a long PR exhibited a higher E/A ratio ( p = 0.03) and lower LA volume ( p = 0.03).
We also stratified the patients to those who prolonged their PR interval above or below 40 ms compared to baseline. Patients with PR prolongation ≥ 40 ms had a lower SPAP at 1 month post-TAVI. However, at the 6-month echocardiographic follow-up this difference was no longer observed.
Analysis according to QRS Interval and ΔQRS
We compared diastolic parameters in patients with a narrow (<120 ms) and wide ( ≥ 120 ms) QRS complex ( Table 5 ). Patients with a wide compared to narrow QRS had larger LA ( p = 0.03) measurements at 1 month post-TAVI. However, at 6 months this difference in LA volume was no more evident. A second stratification was of patients who prolonged their QRS compared to baseline (ΔQRS ≥ 40 or <40 ms). There was no significant difference between the 2 groups.
Conduction Disturbance according to Valve Type
The distributions of prolongation in PR or QRS ( ≥ 40 ms) and absolute prolonged PR ( ≥ 200 ms) or QRS ( ≥ 120 ms) were not different between the 2 valve types ( p = n.s. for all calculations).
Survival Rates
Finally, survival analysis was performed in patients with normal and long PR, ΔPR above or below 40 ms, narrow and wide QRS, and ΔQRS above or below 40 ms. The mean follow-up was 1,102 ± 315 days (median 1,108 Figure 1 , there was no significant difference in overall survival between patients stratified by PR interval, or between patients with narrow versus wide QRS or ΔPR and QRS above or below 40 ms.
Discussion
In this study, we report the relation between conduction disturbances and diastolic function in post-TAVI patients. We found that patients may develop conduction disturbance represented as QRS prolongation. This finding has been widely described before [6] [7] [8] and is explained by traumatic damage of the implanted valve to the His and left bundle branch, which penetrate the membranous septum a few millimeters below the right and noncoronary cusp [11] . Postprocedural PR prolongation have also been reported by several research groups [20, 21] . However, in the current study only an insignificant trend to PR prolongation was found. This difference may be explained by the relatively small sample size. Evaluation of the echocardiographic variables showed a reduction in SPAP. In the setting of TAVI, this finding is suggestive of an improved left-sided loading condition and is consistent with previous reports, demonstrating improved LV filling properties [9] [10] [11] . Hoffman et al. [22] analyzed 90 TAVI patients, of whom 39 (43%) developed a new QRS widening. LVEF improved only in patients without new conduction defects. Urena et al. [23] showed that LBBB post-TAVI is associated with a lack of improvement in LVEF, and a poorer functional status. None of the abovementioned studies, or other studies [22, [24] [25] [26] to the best of our knowledge, evaluated the influence of conduction abnormalities on diastolic properties post-TAVI.
Our study demonstrated a lower LA volume and elevated E/A ratio in patients with a longer PR at 6 months post-TAVI. This finding is somewhat unexpected and merits further validation in future studies, as long PR is associated with a shorter LV diastolic filling time. A partial explanation may be related to our cutoff of 200 ms for defining long PR. Whether or not a higher cutoff would better demonstrate the effect of shorter diastolic filling cannot be answered by the current study. It is also important to stress that we found a trend for a longer RR interval in patients with a longer PR, which might explain the improvement in diastolic indices.
A higher LA volume was also demonstrated at 1 but not at 6 months after TAVI in patient with a wide QRS. This finding is consistent with the negative influence on LV filling performance.
Several studies have reported the relationship between LA volume and diastolic function following TAVI. Spethmann et al. [27] reported an acute improvement in the reservoir and conduit function of the LA accompanied by improvement of LV diastolic function within 8 days of the procedure. Aslan et al. [28] reported that TAVI is associated with improved LA appendage function, especially in patients with a marked diastolic dysfunction. According to our findings, these positive improvements in LA dimensions and function may be attenuated early by the development of wide QRS.
In order to evaluate whether the change in conduction, which is caused by the TAVI procedure itself, and not only the absolute values of PR and QRS may affect diastolic parameters, we divided the patients to those with and without PR or QRS prolongation compared to baseline. Except for a lower SPAP at 1 month but not at 6 months after the procedure in patients who experienced PR prolongation, no other significant change in diastolic parameters was observed. This may suggest that ΔPR and ΔQRS do not significantly affect diastolic parameters post-TAVI.
In the current study, most diastolic parameters, except for LA volume and SPAP at 1 month, were not influenced by conduction abnormalities. Furthermore, we were unable to identify a strong and reliable direct correlation between conduction indices and their changes during follow-up and diastolic function indices and their changes. Also, and most importantly, no survival difference was found between patients with or without conduction abnormalities or prolongation following the procedure.
Limitations
The small sample size precluded us from subanalyzing the net effect of different conduction disturbances without the influence of others. For example, separately analyzing patients with a long or normal PR interval, but with a comparable RR interval or QRS width. Also, other powerful variables like patient age, comorbidities, and paravalvular leak may have a significant effect on diastolic function, possibly masking the effect of conduction disturbances.
In conclusion, in this study LA volumes and SPAP at 1 month were found to be mildly influenced by conduction abnormalities following TAVI. No clear and significant relationships were found between conduction abnormalities and other diastolic parameters. A possible explanation is that, on the one hand, conduction disturbance impairs diastolic function, whilst on the other hand, TAVI improves it, making the net effect on diastolic function is null.
